Industry Information
-
100-µg booster dose of Moderna’s vaccine increases antibody levels 83 times against Omicron
Moderna is touting preliminary data suggesting that its COVID-19 vaccine booster led to robust antibody increases against the Omicron variant, both at the 50 µg and 100 µg dose levels.2021-12-23 -
FDA approves Bristol Myers Squibb drug to prevent graft versus host disease
On November 15, the FDA approved Bristol Myers Squibb’s Orencia (abatacept) for the prophylaxis (prevention) of acute graft versus host disease (aGVHD).2021-12-22 -
FDA authorizes AstraZeneca’s Evusheld for the pre-exposure prophylaxis of COVID-19
AstraZenecaFDA issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld antibody cocktail as pre-exposure prophylaxis for COVID-19.2021-12-10 -
Visus Therapeutics touts data from trial of presbyopia treatment
On November 30, Visus Therapeutics announced today that three novel presbyopia treatments achieved their improvement endpoints in a Phase 2 study.2021-12-08 -
FDA approves novel treatment for post-transplant CMV infection
FDA has approved Takeda Pharmaceutical’s Livtencity (maribavir) for use in patients at least 12 years old with post-transplant cytomegalovirus (CMV) infection or disease that does not respond to available antiviral therapy.2021-11-26 -
Pfizer to make COVID-19 pill available in low- and middle-income nations
MPP/PfizerIn late October, Merck and its partner Ridgeback Biotherapeutics agreed to make the COVID-19 antiviral molnupiravir available in the developing world.2021-11-23
